Other substances

Motesanib

A tyrosine kinase inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Motesanib on PubChem

 

Structure image - Motesanib

CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C

Supporting references

Link Tested on Impact factor Notes Publication date
The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States
Preprint 		in silico

one of the top drugs and compounds identified by ViroTreat

 May/17/2020
Export (.csv)